NasdaqGM - Nasdaq Real Time Price USD
Xencor, Inc. (XNCR)
9.10
-0.05
(-0.55%)
At close: June 4 at 4:00:00 PM EDT
9.47
+0.37
+(4.07%)
After hours: June 4 at 6:02:30 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-161,549
-202,188
-77,926
24,485
-16,853
Investing Cash Flow
-26,522
-7,872
-111,065
-119,725
-46,249
Financing Cash Flow
196,614
197,152
189,219
5,702
43,038
End Cash Position
39,959
41,262
54,170
53,942
143,480
Income Tax Paid Supplemental Data
--
6,100
0
700
0
Interest Paid Supplemental Data
23
33
22
13
14
Capital Expenditure
-9,895
-9,512
-21,251
-43,404
-15,981
Issuance of Capital Stock
--
201,256
0
0
28,920
Free Cash Flow
-171,444
-211,700
-99,177
-18,919
-32,834
12/31/2021 - 12/3/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MGNX MacroGenics, Inc.
1.5000
-0.66%
CGEM Cullinan Therapeutics, Inc.
9.07
+1.23%
NRIX Nurix Therapeutics, Inc.
12.16
+0.66%
BCYC Bicycle Therapeutics plc
8.46
+1.93%
FHTX Foghorn Therapeutics Inc.
4.2000
-3.67%
ENTA Enanta Pharmaceuticals, Inc.
7.11
-1.11%
EWTX Edgewise Therapeutics, Inc.
14.49
-2.36%
RLAY Relay Therapeutics, Inc.
3.2300
-1.82%
ARTV Artiva Biotherapeutics, Inc.
1.9700
+1.03%
SYRE Spyre Therapeutics, Inc.
16.52
-0.30%